- Research Article
- 10.1016/j.jogoh.2026.103160
Dyspareunia and sexual dysfunction after transvaginal specimen extraction - A systematic review.
- May 01, 2026
- Journal of gynecology obstetrics and human reproduction
- Cihan Kaya + 6 more +6
Publications from 2021 to 2026
Showing 10 of 782 papers
Dyspareunia and sexual dysfunction after transvaginal specimen extraction - A systematic review.
Closed-loop synchronization versus conventional synchronization in spontaneously breathing pediatric patients (CHESTSIPP) - a randomized controlled cross-over study.
Patient-ventilator asynchrony (PVA) is common during invasive mechanical ventilation in children and may increase respiratory workload and discomfort. The IntelliSync+ (IS+) algorithm provides closed-loop synchronization by continuously analyzing airway pressure and flow waveforms to optimize inspiratory and expiratory cycling in real time. This study evaluated the efficacy and safety of IS+ compared with conventional physician-tailored synchronization in spontaneously breathing pediatric patients. Multicenter, prospective, randomized controlled, single-blind crossover trial conducted in four pediatric intensive care units between March 2024 and May 2025. Patients aged 1 month to 18 years undergoing invasive mechanical ventilation were randomized to begin with either IS+ or conventional synchronization. Each mode was applied for 90 min (30-min run-in and 60-min measurement), separated by a 30-min washout period. The primary outcome was the Asynchrony Index (AI). Secondary outcomes included major and minor asynchrony indices, Comfort-B scores, end-tidal carbon dioxide (EtCO2), oxygen saturation (SpO2), and leak percentage. Twenty-five patients completed both study phases. Compared with conventional synchronization, IS+ significantly reduced the overall AI (median 5.1% [IQR 4.2-6.4] vs. 12.4% [IQR 9.9-15.6]; P < 0.001), as well as both major and minor asynchrony indices (P < 0.001 for both). The frequencies of double triggering, auto-triggering, trigger delay, and early cycling decreased significantly, while ineffective efforts were unchanged and late cycling slightly increased. Comfort-B scores improved modestly (P = 0.02) and EtCO2 decreased (P < 0.001), whereas SpO2 and leak remained stable. Closed-loop synchronization with IS+ significantly improved patient-ventilator interaction without compromising comfort, oxygenation, or safety. These results support closed-loop synchronization as a feasible and physiologically sound strategy for improving ventilatory support quality in pediatric invasive mechanical ventilation. [ClinicalTrials.gov], identifier [NCT05731024].
Read morePO 275 Glutamatergic excitotoxicity in early-stage MS: CSF findings in OCB Type 2 via 1H-NMR spectroscopy
EVALUATION OF THE EFFECTS OF miR-21-5p, miR-125b-5p, AND miR-196a-3p ON PANCREATIC CANCER CELL MIGRATION AND INVASION
Objective: Pancreatic cancer is one of the most aggressive malignancies and is characterized by early dissemination and poor prognosis. MicroRNAs (miRNAs) are important post-transcriptional regulators of gene expression and have been implicated in pancreatic cancer progression. In this study, we evaluated the functional effects of miR-21-5p, miR-125b-5p, and miR-196a-3p in human PANC-1 pancreatic cancer cells. These miRNAs were selected based on preliminary observations from previous analyses identifying them among the most upregulated candidates in pancreatic cancer–associated miRNA profiles. Methods: Gain- and loss-of-function approaches were performed using miRNA mimics and inhibitors. Cell migration and invasion were assessed using wound healing and Matrigel transwell assays, respectively. Epithelial mesenchymal transition (EMT)-associated protein expression was analyzed by Western blotting at 24 and 48 hours following transfection. Results: Kaplan–Meier survival analysis demonstrated that high expression of miR-21-5p and miR-196a was associated with reduced overall survival, whereas miR-125b-5p showed no significant prognostic association. Functional assays revealed that miR-125b-5p significantly modulated PANC-1 cell migration, while miR-21-5p exerted time-dependent effects on migratory capacity. In contrast, modulation of these miRNAs did not result in significant changes in invasive behavior. Analysis of EMT-associated markers showed limited alterations, with reduced N-cadherin expression observed following inhibition of miR-125b-5p and miR-196a-3p at early time points. Conclusion: Overall, this study provides a general functional insight into miRNA-mediated regulation of pancreatic cancer cell motility. Further studies employing more complex in vitro systems and in vivo models are needed to fully elucidate the roles of these miRNAs in pancreatic cancer progression.
Read moreThe Soothing Touch of Water: Maternal Comfort and Neonatal Outcomes in Hydrotherapy-Assisted Labor.
This study aims to evaluate the impact of hydrotherapy-assisted labor on maternal and neonatal outcomes compared to conventional vaginal delivery. A retrospective cohort study was conducted at Bilkent City Hospital between 2019 and 2024, including 408 women divided into four groups: 102 primiparous and 102 multiparous women in the hydrotherapy group and 102 primiparous and 102 multiparous women in the conventional delivery group. Maternal outcomes included labor pain (VAS scores), labor duration, perineal trauma, and postpartum complications, while neonatal outcomes included Apgar scores, NICU admission rates, and birth weights. Systemic inflammatory markers (NLR, PLR) were analyzed for their association with cesarean delivery risk. Statistical analyses were performed using SPSS 25.0, with a significance level of p < 0.05. Hydrotherapy-assisted labor was associated with significantly higher vaginal delivery rates in both primiparous (85.29% vs. 80.39%, p = 0.04) and multiparous women (85.29% vs. 81.37%, p = 0.04). VAS pain scores at 6 cm cervical dilation and at 6 h postpartum were significantly lower in the hydrotherapy groups across both parity strata (all p = 0.01). The incidence of third- and fourth-degree perineal tears and postpartum infection-related hospitalization was significantly reduced in the hydrotherapy groups. Neonatal outcomes were favorable, with higher Apgar scores at 1 and 5 min and lower NICU admission rates among women undergoing hydrotherapy-assisted labor. Within the hydrotherapy cohort, women who required cesarean delivery exhibited significantly higher PLR and WBC/neutrophil ratio values and distinct NLR patterns compared with those who achieved vaginal birth. ROC analyses demonstrated moderate discriminatory performance of NLR, PLR, and WBC/neutrophil ratio for predicting cesarean delivery. Hydrotherapy-assisted labor provides significant maternal pain relief, reduced perineal trauma, and improved neonatal outcomes, with no increased risks. The association between systemic inflammatory markers and labor progression highlights the need for further research. Hydrotherapy should be considered a safe and effective alternative for labor management in properly selected cases.
Read moreAbstract PS1-09-11: Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer
Abstract Background: De novo metastatic breast cancer (MBC) presents distinct clinical challenges and accounts for a small proportion of all breast cancer cases. While extensive data exist for female patients, the characteristics and outcomes of male patients with de novo MBC remain poorly defined. Comparing clinicopathological features and prognoses between male and female patients may help improve personalized management strategies for this rare subgroup. In this study, we compared the clinicopathological features and prognoses of male and female patients diagnosed with de novo metastatic breast cancer. Method: This retrospective study utilized data from the Surveillance, Epidemiology, and End Results (SEER) database, including male and female patients diagnosed with de novo metastatic breast cancer, between 2000 and 2021. Demographic and clinicopathological variables were collected to compare baseline characteristics. Survival outcomes were assessed using Kaplan-Meier analysis, and multivariate Cox regression was performed to identify independent prognostic factors. Statistical analyses were conducted using SPSS version 30.0. Results: A total of 60,590 patients met the study criteria. Of these patients, 713 (1.2%) were male. 56.1% were under 65 years of age. Pathological subtypes were HR+/HER2- (61.2%), HR+/HER2+ (15.9%), HR-/HER2- (14.3%), and HR-/HER2+ (8.6%). All patients had de novo metastatic disease. Metastatic sites were bone (64.2%), lung (30%), distant lymph node (27%), liver (24.2%), brain (7.3%), and other (18%). At the time of diagnosis, statistically significant differences were detected in patient groups in terms of age (p&lt;0.001), marital status (p&lt;0.001), origin (p&lt;0.001), race (p&lt;0.001), histologic type (p&lt;0.001), breast cancer subtype (p&lt;0.001), liver metastasis (p&lt;0.001), lung metastasis (p&lt;0.001) 5-year survival of de novo metastatic female breast cancer patients was found to be better than male patients (31.4% vs. 25.6%, p = 0.036). Conclusions: Male breast cancer is quite rare. The clinicopathological features and metastatic spread of male and female patients at diagnosis differ. Female patients were found to have a better survival rate. Citation Format: I. Dogan, A. Azizy, I. D. Subası, I. Yıldız, A. Arican, S. Yücel, O. Dülgeroğlu, M. Bozkurt, C. Uras. Comparison of Clinicopathological Features and Prognoses in Male and Female Patients with Denovo Metastatic Breast Cancer [abstract]. In: Proceedings of the San Antonio Breast Cancer Symposium 2025; 2025 Dec 9-12; San Antonio, TX. Philadelphia (PA): AACR; Clin Cancer Res 2026;32(4 Suppl):Abstract nr PS1-09-11.
Read moreComparative Analysis of Functional and Morphological MRI Biomarkers in Assessing Cirrhosis Severity
<title>Abstract</title> Purpose The severity of liver cirrhosis is primarily assessed through biochemical tests. However, relying only on laboratory parameters limits the ability to evaluate hepatocellular function and structural damage. Imaging biomarkers obtained from liver MRI offer noninvasive information that could improve severity assessment. This study aims to explore the potential of functional and morphological imaging biomarkers in determining the severity of liver disease. Materials and Methods This retrospective single-center study involved patients with cirrhosis who underwent gadoxetic acid–enhanced MRI (GA-MRI). The Functional Liver Imaging Score (FLIS), which reflects hepatic function, was assessed on hepatobiliary-phase images. Liver Surface Nodularity (LSN), a measure of structural distortion, was evaluated on MRI using a commercial semi-automated tool. Model for End-stage Liver Disease (MELD-Na) scores were obtained from medical records and served as the clinical reference standard for cirrhosis severity in this study. The associations of FLIS and LSN with MELD-Na were analyzed through correlation analysis, regression modeling, and ROC curve analysis. Results A total of 165 patients (mean age, 59.2 ± 12.5 years; 112 women) were included in the study. FLIS demonstrated a moderate correlation with MELD-Na (ρ = −0.54, p < 0.001), whereas LSN showed a poor correlation (ρ = +0.23, p = 0.004). On ROC analysis, FLIS achieved an AUC of 0.78 (95% CI, 0.70–0.87) for detecting patients with MELD-Na ≥ 15, while LSN showed weaker performance with an AUC of 0.62 (95% CI, 0.52–0.71). The combined FLIS + LSN score showed a marginal improvement in discriminative ability (AUC 0.80 vs 0.78), driven primarily by increased sensitivity (81% vs 70%). Inter-reader agreement (0.86) and intra-reader reliability (ICC = 0.88) were good for FLIS scoring. Conclusion This study indicates that functional and morphological imaging biomarkers provide complementary prognostic information to biochemical scoring, particularly in identifying functional impairment not captured by laboratory tests. Prospective studies involving long-term clinical outcomes are needed to determine their role in risk stratification and transplant decision-making.
Read moreDiscordance Between FIB-4 and BAST Fibrosis Risk Classifications in Obese Patients with MASLD: Results from the OBREDI-TR Study.
Background/Objectives: Non-invasive fibrosis scores are widely used for risk stratification in metabolic dysfunction-associated steatotic liver disease (MASLD); however, their performance in obese individuals remains controversial. The Fibrosis-4 (FIB-4) index is commonly recommended as a first-line tool, yet it may underestimate fibrosis risk in severe obesity. The BAST score, which incorporates metabolic and anthropometric parameters, has been proposed as an alternative. This study aimed to characterize both the degree and direction of discordance between FIB-4 and BAST in obese patients with MASLD. Methods: This predefined secondary analysis included 2950 adults with obesity (BMI ≥ 30 kg/m2) and MASLD from the multicenter OBREDI-TR cohort. Fibrosis risk categories were assigned using standard cut-offs for FIB-4 and BAST, and agreement was assessed using weighted Cohen's kappa. Associations among discordance patterns, obesity class, and the visceral adiposity index (VAI) were evaluated using chi-square tests and general linear models. Results: Overall agreement between FIB-4 and BAST was very poor (κ = 0.041, p < 0.001). Discordance was observed in 22.3% of patients and increased markedly with obesity severity. In class III obesity, discordance was predominantly driven by low-risk classification according to FIB-4 despite high-risk classification according to BAST. Patients with this discordant pattern exhibited significantly higher VAI values than concordant cases (p < 0.001), independently of the study center. Conclusions: In obese patients with MASLD, particularly those with morbid obesity, FIB-4 frequently classifies patients as low risk, while BAST identifies elevated fibrosis risk. This systematic discordance suggests that FIB-4 may underestimate fibrosis burden in the context of severe obesity and visceral adiposity, supporting the need for a phenotype-oriented, multimodal approach to fibrosis risk assessment.
Read moreSialidosis type I: How to alleviate disabling myoclonic seizures?—A multicenter analysis of eight cases and review of the literature
ObjectiveSialidosis type I (ST‐1) is an autosomal‐recessive, very rare, progressive lysosomal storage disorder caused by pathogenic variants in NEU1. It is clinically characterized by progressive ataxia, myoclonic seizures (MS), bilateral tonic–clonic seizures (BTCS), and distinctive ophthalmological findings. Given the lack of curative options, in this study, we investigated symptomatic treatment strategies, with a particular focus on the efficacy of antiseizure medications (ASMs).MethodsWe describe the clinical course of a patient followed from diagnosis to 18 years of age, and review seven additional cases from our cohort. In parallel, we conducted a narrative review of the literature (PubMed, January 2010–September 2025) to identify published reports containing therapeutic data.ResultsTherapeutic responses were evaluated in a total of 33 cases (8 from our cohort, 25 from published sources). Although available data are insufficient to define standardized treatment guidelines, some ASMs, such as ACZ, PER, LEV, VPA, CZP, and ZNS, demonstrated fairly consistent efficacy in managing MS and BTCS. Sodium oxybate or deep‐brain stimulation may be considered in refractory cases.SignificanceProspective documentation of clinical course and treatment outcomes—ideally through an international registry—is crucial to improve patient care and inform therapeutic strategies.Plain Language SummarySialidosis type I (ST‐1) is a very rare genetic disorder causing movement problems and seizures, with no cure available yet. We followed 8 patients and reviewed 25 published cases to assess treatments focusing on myoclonic seizure (MS) control. Some antiseizure medications showed benefit. However, we have too little data to make clear recommendations. To improve patients' treatment and to choose the most appropriate therapy, it would be important to follow patients over a longer period of time, for example, in an international registry.
Read moreShorter Anogenital Distance in Women with Adenomyosis Diagnosed by MUSA 2022 Criteria: A Prospective Case-Control Study.
Objective: The objective was to investigate the association between anogenital distance (AGD) and adenomyosis in reproductive-age women and to evaluate the potential of AGD as a non-invasive biomarker reflecting prenatal hormonal environment. Methods: This prospective case-control study included 40 women with adenomyosis diagnosed according to the Morphological Uterus Sonographic Assessment (MUSA) 2022 criteria and 40 age-matched healthy controls. Two AGD measurements were obtained: AGD-af (anus to posterior fourchette) and AGD-act (anus to clitoral tip). Measurements were performed by two independent observers using vernier calipers. Hormonal parameters, reliability analyses, receiver operating characteristic (ROC) curve analysis, and logistic regression were conducted. Results: Women with adenomyosis had significantly shorter AGD-af compared to controls (23.78 ± 7.20 vs. 27.88 ± 7.50 mm, p = 0.015), whereas AGD-act did not differ significantly (p = 0.574). Inter- and intra-observer reliability was excellent (intraclass correlation coefficient [ICC] = 0.87-0.93). ROC analysis revealed an area under the curve (AUC) of 0.658 (95% confidence interval [CI]: 0.55-0.76) for AGD-af (optimal cut-off = 24 mm; sensitivity: 57.5%, specificity: 67.5%). In multivariate logistic regression, AGD-af remained independently associated with adenomyosis after adjusting for age and body mass index (BMI) (adjusted odds ratio [OR] = 0.925, 95% CI = 0.866-0.989, p = 0.022). No significant difference was observed in hormonal parameters between groups. Conclusions: Women with adenomyosis exhibit a modest but significant reduction in AGD-af, suggesting a possible influence of prenatal hormonal environment in disease pathogenesis. Although its diagnostic accuracy is fair, AGD-af may serve as a complementary, non-invasive biomarker in clinical assessment of adenomyosis.
Read more